Two distinct siRNA sequences specifically targeting human PIPKIγ were: PIPKIγ-siRNA1 (ATCCGCGTCGTGGTCATGAACAACA) and PIPKIγ- siRNA2 (GCGTGGTCAAGATGCACCTCAAGTT). PIPKIγ siRNAs and control siRNA were synthesized at Invitrogen (Stealth RNAi). Mouse PIPKIγ constructs encoding isoform 1 and isoform 2 that are resistant to human PIPKIγ siRNAs were constructed as described previously (6).
For transient transfection of siRNAs, OVCAR-8 and SKOV-3 cells were plated in 6-well culture plates at 4×105 cells/well, and then reversely transfected using Lipofectamine RNAiMAX (Invitrogen) for 48 h before further analyses. For the rescue experiments, SKOV-3 cells were transiently transfected with DNA plasmids using X-tremeGENE 9 (Roche) for 24 h, and then lifted and reversely transfected with siRNAs as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.